Virtu Financial LLC Acquires New Position in The Clorox Company $CLX

Virtu Financial LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 6,071 shares of the company’s stock, valued at approximately $612,000.

A number of other hedge funds have also recently made changes to their positions in CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in Clorox by 4.0% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after purchasing an additional 514 shares during the last quarter. Woodline Partners LP grew its stake in shares of Clorox by 253.7% during the first quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock valued at $1,532,000 after buying an additional 7,465 shares during the last quarter. Baird Financial Group Inc. increased its holdings in shares of Clorox by 1.7% in the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares during the period. Jump Financial LLC lifted its stake in shares of Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after acquiring an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia lifted its stake in shares of Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,352 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Price Performance

Shares of CLX stock opened at $90.61 on Tuesday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The firm has a market cap of $10.96 billion, a P/E ratio of 14.71, a P/E/G ratio of 0.50 and a beta of 0.56. The business’s 50 day moving average price is $95.37 and its 200-day moving average price is $104.70.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.63% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. Wells Fargo & Company dropped their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research note on Monday, May 18th. Royal Bank Of Canada cut their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Evercore reiterated an “underperform” rating and set a $110.00 price target on shares of Clorox in a report on Friday, May 1st. Finally, UBS Group cut their price target on shares of Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.